Subscriber access provided by UNIV OF DURHAM
Article
pH- and GSH-sensitive hyaluronic acid-MP conjugate micelles for intracellular delivery of doxorubicin to colon cancer cells and cancer stem cells Tilahun Ayane Debele, Lu-Yi Yu, Cheng-Sheng Yang, Yao-An Shen, and Chun-Liang Lo Biomacromolecules, Just Accepted Manuscript • DOI: 10.1021/acs.biomac.8b00856 • Publication Date (Web): 25 Jul 2018 Downloaded from http://pubs.acs.org on July 25, 2018
Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.
Page 1 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
1
pH- and GSH-sensitive hyaluronic acid-MP
2
conjugate micelles for intracellular delivery of
3
doxorubicin to colon cancer cells and cancer stem
4
cells
5
Tilahun Ayane Debele†, Lu-Yi Yu†, Cheng-Sheng Yang†, Yao-An Shen⊥ and Chun-Liang Lo†,∥,
6
‡,*
7
† Department of Biomedical Engineering, National Yang-Ming University, Taipei 112, Taiwan
8
∥Center for Advanced Pharmaceutics and Drug Delivery Research, National Yang-Ming
9
University, Taipei 112, Taiwan
10
‡
11
University, Taipei 112, Taiwan
12
⊥Department of Pathology and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins
13
Medical Institutions, Baltimore, MD 21205, USA
14
[*] To whom correspondence and reprint requests should be addressed.
15
Prof. C.L. Lo, E-mail:
[email protected], Fax: + 886-2-2821-0847
Biomedical Engineering Research and Development Center (BERDC), National Yang-Ming
16
1 ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 2 of 46
17
Abstract
18
A dual-sensitive polymeric drug conjugate (HA-SS-MP) was synthesized by conjugating
19
hydrophobic 6-mercaptopurine (MP) to thiolated hyaluronic acid (HA) as the carrier and ligand
20
to deliver doxorubicin (Dox) to parental colon cancer and colon cancer stem cells. Due to the
21
amphiphilic nature of HA-SS-MP, it was self-assembled in the aqueous media and Dox was
22
physically encapsulated in the core of the micelles. The particle size and the zeta potential of the
23
micelle were analyzed by dynamic light scattering (DLS), and the morphology of the micelle
24
was investigated using transmission electron microscopy (TEM). Drug release study results
25
revealed more drug release at pH 5.0 in the presence of GSH than that at the physiological pH
26
value. The cytotoxicity of free Dox was slightly greater than that of Dox-loaded HA-SS-MP
27
micelles. In vitro cytotoxicity of HA-SS-MP and Dox-loaded HA-SS-MP micelles was greater
28
for cancer stem cells (HCT116-CSCs) than for parental HCT116 colon cancer cells and L929
29
normal fibroblast cells. The MTT and flow cytometry results confirmed that free HA
30
competitively inhibited Dox-loaded HA-SS-MP uptake. Similarly, flow cytometry result
31
revealed anti-CD44 antibody competitively inhibited cellular uptake of Rhodamine B
32
isothiocyanate conjugated micelles which strengthen the synthesized micelle is up taken via
33
CD44 receptor. Cell cycle analysis revealed that free drugs and Dox-loaded HA-SS-MP arrested
34
parental HCT116 colon cancer cells at the S phase, while cell arrest was observed at the G0G1
35
phase in HCT116-CSCs. In addition, ex vivo biodistribution study showed that Dox-loaded HA-
36
SS-MP micelles were accumulated more in the tumor region than in any other organ.
37
Furthermore, the in vivo results revealed that Dox-loaded HA-SS-MP micelles exhibited more
38
therapeutic efficacy than the free drugs in inhibiting tumor growth in BALB/C nude mice.
39
Overall, the results suggested that the synthesized micelles could be promising as a stimuli 2 ACS Paragon Plus Environment
Page 3 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
40
carrier and ligand for delivering Dox to colon cancer cells and also to eradicate colon cancer
41
stem cells.
42
Keywords: Hyaluronic acid, Dual sensitive micelle, CD44, colon cancer stem cell
43
44
Cancer has become one of the most dreadful public health problems, causing deaths throughout
45
the world.1, 2 Among the various cancers, colon cancer is the third leading cause of cancer-related
46
mortality in men and women worldwide.3 Although there are several treatment strategies, colon
47
cancer is rarely cured completely due to its recurrence properties.4 Several researchers have
48
demonstrated that this is due to cancer stem cells (a small population of cancer cells) that possess
49
self-renewal and differentiation abilities to generate a new tumor population.5 Cancer stem cells
50
(CSCs) are highly resistant to standard conventional chemotherapy due to different cellular
51
processes, including rapid drug efflux, enhanced repair of damaged DNA, overexpression of
52
detoxifying enzymes, and antiapoptotic proteins.6-8 Hence, several researchers have
53
demonstrated that designing specific therapies targeting CSCs can enhance the survival of
54
patients with cancer, primarily those with drug resistance.9,
55
targeting CSCs is the use of nanocarriers that can regulate drug delivery and release the drug
56
more efficiently.11 Furthermore, nanocarriers can effectively inhibit multiple types of CSCs,
57
including colon cancer stem cells, by targeting specific markers (ALDH, CD44, CD90, and
58
CD133) using targeting ligands on the surface of nanocarriers, which can enhance selectivity and
59
internalization of drugs by CSCs.12-14 Thus, it is very essential to design an agent that can
60
promote the killing of both parental cancer cells and CSCs.
Introduction
10
One of the recent strategies
3 ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 4 of 46
61
In recent years, nano-sized ( 97%), 6-mercaptopurine, doxorubicin (Dox),
109
glutathione (GSH, 99%, Roche), anhydrous dimethyl sulfoxide (DMSO), 1-ethyl-3-(3-
110
dimethylaminopropyl) carbodiimide hydrochloride (EDC), N-hydroxysuccinimide (NHS) and
111
dialysis bag are all purchased from Sigma-Aldrich (St Louis, MO, USA). All other reagents were
112
analytical grade and used without further purification. Water used in all the experiments was
113
purified using an AquaMax-Ultra water purification system (Younglin Co., Anyang, Korea).
114
Synthesis of HA-SS-MP conjugates
115
HA-SS-MP conjugates were prepared in two separate steps. In the first step, thiolated HA were
116
synthesized using L-cysteine by simple modification of our previous methods.33 Briefly, 500 mg
117
of HA (1.32 mmol of carboxyl group) were dissolved in the reagent grade distilled water (20 mL,
118
pH 5.3) and an excess amount of EDC/NHS (2.64 mmol each) were added to activate the
119
carboxyl group of HA and stirred for 6 h at room temperature. Then, 5 mL aqueous solution of
120
L-cysteine (2.64 mmol) was added to form thiolated HA. After 24 h reaction, resulting HA-Cys
121
conjugates were extensively dialyzed against deionized (D.I.) water (MWCO 6-8kDa) for 48 h,
122
within 6 h D.I. exchange, followed by deep freeze and lyophilization. The HA-Cys conjugates
123
(sponge-like products) were stored at 4
124
200 mg of HA-Cys conjugates were dissolved in 25 mL of co-solvents (reagent grade
125
water/DMSO) and three times molar excess of 6-mercaptopurine (MP) (3.96 mmol) was added
126
to form HA-SS-MP. Then, 5 mL of H2O2 (2mM) was added drop wise and the reactants solution
until used for the characterization. On the second step,
6 ACS Paragon Plus Environment
Page 7 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
127
were stirred at room temperature for 24 h. HA-SS-MP prodrug was acquired by extensive
128
dialysis (MWCO 6-8KDa) against DMSO, water/DMSO (1:1, v/v) for 24 h and then D.I. water
129
for the other 48 h followed by deep freezing and lyophilization. 1H-NMR and FTIR were used to
130
confirm thiolated HA and HA-SS-MP formation. In addition, GPC analysis was performed using
131
a shodex OHpack SB-803 column (8mm ID x 300mm L and 9 µm, particle size) to confirm
132
thiolated HA and HA-SS-MP formation. A serious of dextrane polysaccharide (5.2, 11.6, 23.8,
133
48.6 and 148kDa) was used to calculate the molecular weight of polymers. The analysis was
134
carried out using acetonitrile and distilled water (20:80v/v ratio, respectively) as a mobile phase
135
at a flow rate of 1 mL/min.
136
Doxorubicin loading and preparation of HA-SS-MP micelles.
137
Doxorubicin (Dox) loaded HA-SS-MP micelles were prepared using dialysis (solvent exchange)
138
method. Briefly, 20 mg HA-SS-MP, 10mg Dox, and 30µL triethylamine were dissolved in 20
139
mL of DMSO/dH2O. The solution was stirred at room temperature for 4 h and then dialyzed
140
against DMSO for 24 h to remove unloaded Dox and also against D.I water for the other 48 h in
141
order to remove the DMSO and to obtain the Dox-loaded HA-SS-MP micelles. The micellar
142
size, zeta potential, and polydispersity index were determined by DLS measurements using a
143
Malvern Zetasizer Nano S apparatus equipped with a 4.0 mW laser operating at λ = 633 nm and
144
a scattering angle of 90°. All measurements were performed at 25
145
from the average of three measurements. The morphology of micelles was analyzed using
146
transmission electron microscopy (TEM, with a JEOLJEM-2000EX instrument at a voltage of
147
200 kV). Samples were prepared by drop-casting HA-SS-MP and Dox loaded HA-SS-MP
148
solutions onto carbon-coated copper grids and then air-drying at room temperature.
149
Phosphotungstate (PTA) was used as the negative staining via sequential two-droplet methods.
and the data were obtained
7 ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 8 of 46
150
The critical micelle concentration (CMC) of the micelles was determined by a fluorescent
151
spectroscopic method with pyrene as a fluorescence probe.
152
Determination of drug loading of micelles.
153
To determine the drug loading and encapsulation efficiency, 5mg of the freeze-dried micelles
154
were dispersed in 5 mL of PBS (at pH 5.0 in the presence of 10mM GSH) and shook in a water
155
bath at 37
156
spectroscopy at 480 nm using calibration curve from 0.78125 to 400 µg/mL (0.78125, 1.5625,
157
3.125, 6.25, 12.5, 25, 50, 100, 200 and 400 µg/mL). The percentage of drug loading (DL) and
158
encapsulation efficiency (EE) were calculated by the following equations:
159
DL ( wt %) =
for 6 h to release loaded drugs. The Dox concentration was measured by UV-VIS
weight of Dox in the micelle ×100 weight of the Dox − loaded − micelle
160 161
GSH-Responsiveness of Dox loaded HA-SS-MP micelles
162
The GSH responsive behavior of Dox loaded HA-SS-MP micelles was investigated in the
163
presence of GSH using DLS measurement. In brief, an equal volume of GSH (10mM) was
164
mixed with Dox loaded HA-SS-MP micelles solution at different pH values. Then, the solution
165
was incubated on a shaking table at 37
166
DLS at a different time of intervals and change in the morphology also investigated using TEM.
167
and the size change of the micelles was measured by
In vitro release of Dox and MP from the micelles
168
In vitro release behaviors of Dox and MP were investigated in PBS buffer (100 mM, pH 7.4 and
169
5.0) in the presence and absence of 10 mM GSH solution. Briefly, 2 mL of Dox loaded HA-SS-
170
MP solution was transferred to dialysis tubing (MWCO = 6-8 KDa). The dialysis tubing was
8 ACS Paragon Plus Environment
Page 9 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
171
immersed into 10 mL of PBS buffers (100 mM, pH 7.4 and 5.0) in the presence and absence of
172
10 mM GSH solution and kept on a shaking table at 37 . At predetermined time intervals, 2 mL
173
of external buffer solution was withdrawn and replaced with 2 mL of fresh PBS or PBS with 10
174
mM GSH. The amount of released Dox and MP were determined by UV−VIS spectroscopy at
175
480 nm and HPLC, respectively. The HPLC experiments were conducted on the HPLC, C18 (5
176
µm, 150 mm × 4.6 mm i.d) instruments with UV detection at 325 nm. For 6-MP, the mobile
177
phase was a mixture of acetonitrile and methanol at a volume ratio of 20:80 and flow rate of 1.0
178
mL/min. 20 µL of the sample were injected and the drug was detected at 325 nm.
179
In vitro stability and protein adsorption of Dox loaded HA-SS-MP micelles
180
The in vitro stability and protein adsorption of Dox loaded HA-SS-MP were investigated in PBS
181
and protein solutions.34, 35 Briefly, 2 mL (2 mg/mL) of Dox-loaded HA-SS-MP micelle solution
182
were mixed with equal volume of each solution (i.e. 10% (v/v) FBS, 100 mM PBS at pH 7.4 and
183
1wt% fibrinogen). The suspensions were constantly mixed using a sonicator at 37
184
size was measured using DLS at 0, 6, 24 and 48 h.
and particle
185
In vitro cytotoxicity of thiolated HA, HA-SS-MP, Free Dox, Free MP and Dox loaded
186
HA-SS-MP
187
The in vitro cytotoxicity of thiolated HA, HA-SS-MP, Dox loaded HA-SS-MP, free MP and free
188
Dox were evaluated against parental colon cancer cells (HCT116-PC) and L929 fibroblast
189
normal cells using MTT assay. Briefly, all the cells were seeded at a density of 2.5
190
per well in 96-well plates and incubated for 24 h to allow cell attachment. The cells were then
191
incubated in a concentration gradient at 37
192
concentration of: 500, 250, 125, 62.5 and 31.25 µg/mL for each), free Dox and free MP (at Dox
193
and MP concentration of 25, 12.5, 6.25, 3.125 and 1.5625µg/mL) and Dox-loaded HA-SS-MP
104 cells
with thiolated HA and HA-SS-MP (at
9 ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 10 of 46
194
(at Dox concentration of 25, 12.5, 6.25, 3.125 and 1.5625µg/mL for each). After 48 h incubation,
195
the cells were washed with PBS and new medium were added with 20 µl MTT (5 mg/m1) and
196
further incubated for 4 h. The medium in each well was removed and 100 µl DMSO was added
197
to dissolve the internalized purple formazan crystals. The absorbance was measured at the test
198
wavelength (570 nm) and reference wavelength (633 nm) using an enzyme-linked
199
immunosorbent assay (ELISA) reader (Power Wave XS, BioTek, Winooski, VT). Similarly Dox
200
loaded HA-SS-MP cytotoxicity was investigated for cancer stem cells (HCT116-CSCs). The
201
relative cell viability (%) was calculated using the following equation: absorbance of test cells − absorbance of reference ×100 absorbance of controlled cells − absorbance of reference
202
Cell viability (%) =
203
Cellular uptake and competitive inhibition study
204
Parental HCT116 cells and HCT116-CSCs were grown in McCoy’s 5A and DMEM modified
205
medium, respectively, at 37
206
were seeded and grown in a six well plate at a density of 4 × 104 cells/well and incubated at 37
207
under 5% CO2 for 24 h. Cellular uptake competitive inhibition of Dox loaded HA-SS-MP and
208
HA-SS-MP-Rhodamine B isothiocyanate were investigated using flow cytometry after
209
incubating for 1 h at 37
210
respectively. Fluorescence histograms were recorded with a BD FACS Calibur flow cytometer
211
(Becton Dickinson, USA) and analyzed using Cell Quest software.
212
and 5% CO2 according to reported protocol. Briefly, the cells
in the presence and absence of free HA and anti-CD44 antibody
Cell cycle analysis
213
Parental cancer cells and cancer stem cells were treated with HA-SS-MP (500µg/mL), free MP,
214
free Dox and Dox-MP (at the Dox and MP concentrations of 20 and 2 µg/ml, respectively) and
10 ACS Paragon Plus Environment
Page 11 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
215
Dox loaded HA-SS-MP micelles (at Dox concentration of 20µg/mL) for cell cycle analysis.
216
Briefly, cells (1104 cells/well) were seeded on 6-well plates and co-cultured with HA-SS-MP,
217
free MP, free Dox, Dox-MP and Dox loaded HA-SS-MP for 24 h. After incubation, cells were
218
washed three times by PBS, collected by trypsinization, fixed on iced ethanol for 24 h and then
219
centrifuged at 1000 rpm for 5 min to separate suspension and cell pellets. The cell pellets were
220
finely washed by PBS and stained by PI/Triton X-100/ RNAase solution for 30 min at 37
221
FACS Calibur flow cytometer and ModFit LT software were applied for cell cycle analysis.
222
. BD
In vivo biodistribution study
223
Female BALB/C nude mice (6 - 8 weeks of age, 20 g) were obtained from National Yang-Ming
224
University, and kept in filter-topped cages with standard rodent chow and water available ad
225
libitum, with a 12 h light/dark cycle. The experiment protocol was approved by the ethical
226
committee of animal experiment of National Yang-Ming University. Briefly, 2.5 × 106 HCT116
227
colon cancer cells were subcutaneous seeded by inoculation in the front armpit of BALB/C nude
228
mice. After 4 weak of tumor growth (> 500 mm3), Rhodamine B isothiocyanate conjugated Dox-
229
HA-SS-MP (100 µL) was intravenously (i.v.) injected into the tail vein of tumor bearing
230
BALB/C nude mice. The ex vivo fluorescent scans were performed by scarifying mice after 18 h
231
of post-injection using the IVIS imaging system series 50 with an excitation band filter at 563
232
nm and an emission at 581 nm.
233
Ex vivo anti-tumor efficacy study
234
Similar to the above protocols, after 3 weeks of tumor growth (~200 mm3), Dox-loaded HA-SS-
235
MP or free drugs (Dox + MP) were injected via the lateral tail vein at a dose of 5 mg/kg (for each
236
Dox and MP) every 7 days for a total of 3 injections. Vernier caliper was used to measure the
237
tumor sizes every 2 days and volume was measured using the formula: V = L × W ×W × 0.5, 11 ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 12 of 46
238
wherein L and W represent the tumor dimension at the longest and widest point, respectively.
239
Relative tumor volumes were calculated as V/V0 (V0-volume when the treatment was initiated).
240
In addition, relative body weights percent were calculated as W/W0×100 (W0-body weight when
241
the treatment was initiated).
242
Statistical analysis
243
Data are represented as the mean ± standard deviation. All results are representative of at least
244
three sets of independent experiments with samples performed in duplicate or triplicate in each
245
experiment. The significances of the differences were determined using Student's t-test, one
246
tailed, for each paired experiment. *p-value < 0.05 was considered statistically significant in all
247
cases. *p< 0.05, ** p< 0.01, *** p< 0.001.
248
249
12 ACS Paragon Plus Environment
Page 13 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
250
Results and discussion
251
Synthesis and characterization of HA-SS-MP conjugates
252
Today, smart nanocarrier systems have been synthesized for targeted cancer therapy to overcome
253
the adverse effects of drugs on normal cells and to enhance its therapeutic efficacy in the region
254
of interest. In this study, HA-based dual-sensitive polymeric drug conjugates were designed and
255
synthesized with the properties of both targeting and drug delivery against colon cancer cells and
256
cancer stem cells. The HA shell permits a dual function, both as a ligand (i.e., targeting CD44 as
257
a ligand to enhance receptor-mediated endocytosis to internalize nanoparticles) and allowing the
258
conjugation of L-Cys via amide linkage as a spacer to conjugate the hydrophobic MP to form the
259
polymer–drug conjugate. The synthesized HA-SS-MP forms a micelle by a solvent exchange
260
method due to its amphiphilic nature, which in turn enables the encapsulation of Dox anticancer
261
drugs in its hydrophobic core. The micelles can respond in the cancer cell cytoplasm due to
262
excess GSH levels. Similarly, a micelle can respond to a low pH value due to the pKa value of
263
the conjugated MP to thiolated HA. Hence, during disulfide cleavage that occurs after the cell
264
internalization of the micelles into endosomes, Dox and MP are released. As shown in Scheme
265
1, the activated HA carboxyl groups were covalently coupled with the amine groups of L-Cys
266
through the amide linkage to form thiolated HA based on the EDC/NHS chemical approach.
267
Then, the HA-SS-MP conjugates were synthesized via the disulfide linkage between thiolated
268
HA and 6-MP in the presence of H2O2. The synthesis of HA-SS-MP conjugates was confirmed
269
via 1H-NMR (Figure 1), FTIR (Figures S1a and S1b) spectra, and GPC (Figure S2). The 1H-
270
NMR spectrum (Figure 1) demonstrated the presence of both HA and L-Cys, which indicated
271
the successful formation of thiolated HA. The
272
monosaccharide units of HA (H-1 from
1
H-NMR peaks of the major repeating
D-glucuronic
acid and H-1 from N-acetyl-D13
ACS Paragon Plus Environment
Biomacromolecules 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Page 14 of 46
273
glucosamine) were found at 4.35 and 4.55 ppm, respectively. The other protons of HA
274
disaccharide units (H-2, H-3, H-4, H-5, and H-6) were found at approximately 3.2–3.9 ppm.36
275
Furthermore, the proton signal of the acetyl groups of HA was found at 1.9 ppm. After thiolation
276
with L-Cys, the new 1H-NMR spectrum was observed at 2.8–3.08 ppm in the HA–Cys conjugate.
277
The degree of thiolation was determined by considering the ratio of the integral of the HA
278
methyl proton peak (at ~1.9 ppm) to that of the protons of L-Cys (at ~2.85 ppm). The degree of
279
thiolation was calculated as 95.52%. Similarly, the 1H-NMR spectrum of HA-SS-MP showed the
280
successful conjugation of MP to thiolated HA via a disulfide bond. The 1H-NMR spectrum of
281
HA-SS-MP showed signals at 8.3–8.41 ppm, which could be assigned to the MP moiety. The
282
degree of substitution was approximately 13.33%, as calculated by comparing the integrals of
283
signals at 7.3–7.41 ppm for MP and 2.85 ppm for methylene protons of L-Cys. Moreover, the
284
degree of substitution was confirmed by UV-VIS measurement (about 12%) after excess GSH
285
treatment at 333 nm, which was almost similar to the 1H-NMR results. Similar to previous
286
reports, the percentage of MP conjugation with thiolated HA was low, which is due to the low
287
reactivity and the low thiol content of MP.29, 37 The chemical structures of the thiolated HA and
288
HA-SS-MP were further confirmed using FTIR (Figures S1a and S1b). All major characteristic
289
peaks of HA–Cys and HA-SS-MP were observed within the range of 3600–500 cm−1. Several
290
major peaks were observed at 3325 cm−1 (HA hydroxyl stretching), 2883–2915 cm−1 (C-H
291
stretching), 1620 cm−1 (amide carbonyl, C=O), 1549 cm−1 (amide, N-H), 1350–1400 cm−1
292
(aromatic, C-N and C=C stretching of MP), and 1027 cm−1 (C-H bending), all of which
293
confirmed the formation of thiolated HA and HA-SS-MP conjugates. In addition, the synthesis
294
of HA–Cys and HA-SS-MP conjugates was further confirmed by GPC analysis. The result
295
(Figure S2) revealed that the retention times of HA, HA–Cys, and HA-SS-MP conjugates were
14 ACS Paragon Plus Environment
Page 15 of 46 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60
Biomacromolecules
296
5.69, 5.14, and 4.92 min, respectively. The decrement in the retention time after the formation of
297
the HA conjugates confirmed the successful formation of thiolated HA and HA-SS-MP,
298
supporting the NMR and FT-IR results.
299
Preparation and characterization of HA-SS-MP micelles
300
Due to their amphiphilic nature, the HA-SS-MP conjugates could self-assemble into micelles in
301
an aqueous solution. The micellization behavior of HA-SS-MP was confirmed by measuring the
302
CMC value using pyrene as a fluorescent probe. The CMC value of the amphiphilic HA-SS-MP
303
conjugates was determined using the excitation intensity ratio of I334/I338 vs a prodrug
304
concentration (Log C). As the concentration of HA-SS-MP increased and reached the CMC
305
value, the hydrophobic pyrene molecules were preferentially solubilized in the core of the
306
micelles, by which the intensity ratio decreased. As shown in Figure S3a, the CMC value of the
307
amphiphilic HA-SS-MP conjugates was determined to be